Risk factor changes and incident atrial fibrillation among middle-aged men in the Malmö Preventive Project cohort

14Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims To determine whether risk factor changes over 6 years were associated with the incidence of atrial fibrillation (AF) among middle-aged men in the Malmö Preventive Project (MPP) cohort. Methods In total, 5633 men (mean age 47.0 years at baseline) underwent two screening examinations, separated by an average of and results 6 years. The annual rate at which systolic blood pressure (SBP), diastolic blood pressure (DBP), weight, fasting blood glucose (FBG), blood glucose at 2-h oral glucose tolerance test (OGTT), and screening spirometry values changed was calculated and analysed in relation to incident AF, using Cox and competing risks regression to determine hazard ratios (HRs) and 95% confidence intervals (CIs). Mean follow-up time + SD from rescreening was 22.3 + 7.4 years. Significant associations were found between the annual increase of SBP (HR: 1.04, 95% CI: 1.01 - 1.07, P ¼ 0.003 per mmHg), DBP (HR: 1.06, 95% CI: 1.01 - 1.1, P ¼ 0.024 per mmHg), FBG (HR: 2.11, 95% CI: 1.44 - 3.12, P, 0.0001 per mmol/L), and weight (HR: 1.14, 95% CI: 1.05 - 1.24, P ¼ 0.003 per kg) on the one hand and incident AF on the other, after full adjustment for baseline age, height, weight, SBP, FBG, smoking status, sedentary lifestyle, anti-hypertensive treatment, screening year, and low socioeconomic status. Conclusion The age-adjusted annual rates of increase in SBP, DBP, weight, and FBG in mid-life are associated with AF incidence in men. This raises the question of whether preventive measures directed at individuals with high annual increases, even within the normal range, would reduce AF incidence.

Cite

CITATION STYLE

APA

Johnson, L. S. B., Juhlin, T., Engström, G., & Nilsson, P. M. (2016). Risk factor changes and incident atrial fibrillation among middle-aged men in the Malmö Preventive Project cohort. European Heart Journal - Cardiovascular Pharmacotherapy, 2(2), 81–87. https://doi.org/10.1093/ehjcvp/pvv056

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free